[Bacteriological studies in outpatients with acute urinary tract infections with particular reference to the resistance spectrum (author's transl)].
Bacteriological investigation of urinary samples from 1,926 non-hospitalised patients with documented or suspected acute urinary tract infection revealed organisms pathogenic for the urinary tract in 56.4% of the patients, who came from various parts of West Germany. Prevalent pathogens were E. coli (69%) and Proteus mirabilis (14%). E. coli and P. mirabilis demonstrated a low rate of resistance against ampicillin, the cephalosporines, gentamicin, tobramycin, and also against nitrofurantoin, nalidixine acid and trimethoprimsulfamethoxazole. The situation was more unfavourable in the case of Klebsiella and indolpositive Proteus species however, there being a noticeably high proportion of strains resistant to gentamicin and tobramycin.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification*; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D009268:Nalidixic Acid / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D010403:Penicillin Resistance; D011513:Proteus mirabilis / Q000187:drug effects / Q000302:isolation & purification*; D014031:Tobramycin / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D002511:Cephalosporins; D005839:Gentamicins; D009268:Nalidixic Acid; D000667:Ampicillin; D009582:Nitrofurantoin; D014295:Trimethoprim; D014031:Tobramycin
Bakteriologische Untersuchungen bei ambulanten Patienten mit akuten Harnwegsinfektionen unter besonderer Berücksichtigung des Resistenzspektrums